Simon Quick Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.97M | Buy |
5,814
+93
| +2% | +$95K | 0.28% | 60 |
|
|
2026
Q1 | $5.26M | Sell |
5,721
-1,296
| -18% | -$1.31M | 0.24% | 67 |
|
|
2025
Q4 | $7.54M | Buy |
7,017
+2,221
| +46% | +$2.12M | 0.33% | 54 |
|
|
2025
Q3 | $3.66M | Buy |
4,796
+621
| +15% | +$462K | 0.17% | 91 |
|
|
2025
Q2 | $3.25M | Sell |
4,175
-1,933
| -32% | -$1.5M | 0.16% | 88 |
|
|
2025
Q1 | $5.04M | Buy |
6,108
+1,204
| +25% | +$1M | 0.29% | 40 |
|
|
2024
Q4 | $3.79M | Buy |
4,904
+123
| +3% | +$102K | 0.23% | 46 |
|
|
2024
Q3 | $4.24M | Buy |
4,781
+675
| +16% | +$607K | 0.27% | 43 |
|
|
2024
Q2 | $3.72M | Sell |
4,106
-158
| -4% | -$126K | 0.26% | 45 |
|
|
2024
Q1 | $3.32M | Buy |
4,264
+1,337
| +46% | +$952K | 0.25% | 52 |
|
|
2023
Q4 | $1.71M | Buy |
2,927
+278
| +10% | +$162K | 0.15% | 82 |
|
|
2023
Q3 | $1.42M | Buy |
2,649
+775
| +41% | +$399K | 0.13% | 87 |
|
|
2023
Q2 | $879K | Buy |
1,874
+215
| +13% | +$90.2K | 0.08% | 111 |
|
|
2023
Q1 | $570K | Buy |
1,659
+807
| +95% | +$272K | 0.06% | 141 |
|
|
2022
Q4 | $312K | Buy |
+852
| New | +$302K | 0.04% | 172 |
|
|
2022
Q2 | – | Sell |
-353
| Closed | -$101K | – | 300 |
|
|
2022
Q1 | $101K | Buy |
353
+7
| +2% | +$1.8K | 0.03% | 144 |
|
|
2021
Q4 | $96K | Buy |
346
+68
| +24% | +$17.2K | 0.03% | 164 |
|
|
2021
Q3 | $64K | Buy |
278
+33
| +13% | +$8.14K | 0.02% | 218 |
|
|
2021
Q2 | $56K | Sell |
245
-1
| -0.4% | -$201 | 0.01% | 228 |
|
|
2021
Q1 | $45K | Sell |
246
-299
| -55% | -$58.5K | 0.01% | 275 |
|
|
2020
Q4 | $92K | Buy |
545
+302
| +124% | +$45.1K | 0.03% | 149 |
|
|
2020
Q3 | $36K | Sell |
243
-39
| -14% | -$6.04K | 0.01% | 234 |
|
|
2020
Q2 | $46K | Hold |
282
| – | – | 0.02% | 198 |
|
|
2020
Q1 | $39K | Sell |
282
-56
| -17% | -$7.69K | 0.01% | 217 |
|
|
2019
Q4 | $44K | Buy |
338
+300
| +789% | +$34.8K | 0.02% | 242 |
|
|
2019
Q3 | $4K | Sell |
38
-97
| -72% | -$10.8K | ﹤0.01% | 319 |
|
|
2019
Q2 | $15K | Buy |
+135
| New | +$15.9K | 0.01% | 199 |
|
|
2018
Q2 | – | Sell |
-57
| Closed | -$4K | – | 367 |
|
|
2018
Q1 | $4K | Buy |
57
+1
| +2% | +$81 | ﹤0.01% | 270 |
|
|
2017
Q4 | $5K | Sell |
56
-3,159
| -98% | -$269K | ﹤0.01% | 366 |
|
|
2017
Q3 | $275K | Sell |
3,215
-1
| -0% | -$82 | 0.1% | 90 |
|
|
2017
Q2 | $265K | Sell |
3,216
-28
| -0.9% | -$2.28K | 0.15% | 55 |
|
|
2017
Q1 | $273K | Buy |
+3,244
| New | +$260K | 0.16% | 66 |
|
Other funds holding LLY
Simon Quick Advisors's LLY Position: Q2 2026 in Review
Simon Quick Advisors increased its Eli Lilly (LLY) stake by 1.6% in Q2 2026, buying an estimated $95K and bringing the position to 5,814 shares worth $6.97M. The position accounts for 0.28% of the portfolio, ranked #60.
Simon Quick Advisors first reported a position in LLY in Q1 2017 and has held it in 32 quarters since. The position peaked at $7.54M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Simon Quick Advisors held 5,814 shares of Eli Lilly worth $6.97M as of Q2 2026.
- Simon Quick Advisors bought 93 Eli Lilly shares in Q2 2026, an estimated $95K.
- Eli Lilly made up 0.28% of Simon Quick Advisors's portfolio in Q2 2026, its #60 holding.
- Simon Quick Advisors first reported a position in Eli Lilly in Q1 2017 and has held it in 32 quarters since.
- Simon Quick Advisors's Eli Lilly position peaked at $7.54M in Q4 2025.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Simon Quick Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.